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background:  Electrocardiographic (ECG) left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular (CV) morbidity and 
mortality. However, the predictive value of ECG LVH in treated hypertensive patients remains unclear.
Methods:  A total of 42 418 patients (aged ≥55 years) with hypertension and at least 1 other coronary heart disease (CHD) risk factor 
were randomized to chlorthalidone (C), amlodipine (A), lisinopril (L) or doxazosin. In addition, 10 355 patients with mild-to-moderate 
hypercholesterolemia were randomized to pravastatin or usual care. The primary outcome of this study was fatal CHD or nonfatal MI 
analyzed by intent to treat; and secondary outcomes included stroke, new-onset heart failure [NOHF] and total mortality.
Results:  ECGs were available at baseline in 28 543 patients randomized to C, A, or L who were included in this study. Baseline Cornell 
voltage LVH (S in V3 + R in aVL > 28 [men] or >20 mm [women]) was present in 2 895 (10%) patients, who were older (68 vs. 67 years, 
p<0.001), more likely to be female (77 vs. 42%, p<0001) with a higher systolic blood pressure (150 vs. 146 mmHg, p<0.001) than patients 
without ECG LVH. During 5.0 ±1.4 years mean follow-up, baseline ECG LVH was significantly associated with CHD, stroke, NOHF and 
total mortality in univariate and multivariate Cox analyses (Figure, all p<0.001).
conclusion:  Baseline Cornell voltage LVH is associated with increased CV morbidity and mortality in treated hypertensive patients 
independent of treatment modality. 
